ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Smokers’ Quitlines Work, California Study Finds

October 25, 2002

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003

Beyond Planned Parenthood: Attendance Flags at Komen Flagship Race, D.C. Participation Drops by Nearly One-Third

June 8, 2012

Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.

September 15, 2006

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982